Approval based on compelling safety and efficacy from the Phase 3 MARIPOSA-2 study, marking the third new indication for RYBREVANT® this year, with four indications overall RARITAN, N.J. , Sept. 17, 2024 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) approved RYBREVANT® (amivantamab-vmjw) in combination with standard of care chemot...
SINGAPORE, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Johnson & Johnson (J&J), a leading healthcare company, announced its 50th anniversary in Singapore. Guided by Our Credo to put the needs and well-being of the people we serve first, J&J has been, and continues to be, dedicated to improving the lives of Singaporeans through innovative medicines and cutting-edge medtech solutions.
Dividend stocks are all-weather investments for buy-and-hold investing because they can help reduce portfolio volatility while generating income. Buying them when they are down and building a solid position is the recipe for market-beating total returns over time.
An Oregon judge has overturned a $260 million verdict against Johnson & Johnson in a lawsuit brought by a woman who said she got mesothelioma, a deadly cancer linked to asbestos exposure, from inhaling the company's talc powder, the company said on Monday.
The ultra-wealthy invest in assets like stocks, real estate, and businesses. These strategies can provide insight into how everyday investors can build lasting wealth. In today's uncertain market, focusing on high-quality dividend stocks and underperforming sectors offers better risk/reward than sticking to overvalued tech stocks. By adapting the smart money's approach to infrastructure and div...
TAR-200 plus cetrelimab effective in reducing tumor size in those with muscle-invasive disease, potentially improving surgical outcomes and lowering risk of recurrence BARCELONA, Spain , Sept. 16, 2024 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announced today interim data from the ongoing Phase 2 SunRISe-4 study showing neoadjuvant treatment with investigational TAR-200 plus cetrelimab (CET...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.